| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 713 | 3.202 | 4.647 | 2.933 | 1.851 | 2.891 | 2.773 | 3.277 | 2.885 |
| Total Income - EUR | - | 713 | 3.202 | 4.647 | 2.933 | 1.851 | 2.891 | 2.773 | 3.277 | 2.885 |
| Total Expenses - EUR | - | 65 | 1.620 | 2.103 | 2.685 | 1.500 | 1.697 | 587 | 1.530 | 1.279 |
| Gross Profit/Loss - EUR | - | 648 | 1.581 | 2.544 | 248 | 350 | 1.193 | 2.186 | 1.747 | 1.606 |
| Net Profit/Loss - EUR | - | 626 | 1.485 | 2.405 | 160 | 295 | 1.108 | 2.114 | 1.427 | 1.331 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cardiosana Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 692 | 2.316 | 4.807 | 4.728 | 4.940 | 5.922 | 8.389 | 9.879 | 11.939 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 239 | 1.352 | 0 | 0 | 522 | 0 | 0 | 1.269 | 31 |
| Cash | - | 453 | 965 | 4.807 | 4.728 | 4.418 | 5.922 | 8.389 | 8.611 | 11.908 |
| Shareholders Funds | - | 671 | 2.145 | 4.510 | 4.583 | 4.791 | 5.793 | 7.925 | 9.328 | 10.607 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 21 | 172 | 298 | 145 | 149 | 129 | 464 | 552 | 1.332 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiosana Srl-D